Eric Quéméneur
Chief Tech/Sci/R&D Officer bij TRANSGENE
Actieve functies van Eric Quéméneur
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TRANSGENE | Chief Tech/Sci/R&D Officer | 01-09-2014 | - |
| ELSALYS BIOTECH | Director/Board Member | - | - |
| Chief Tech/Sci/R&D Officer | - | - |
Loopbaan van Eric Quéméneur
Eerdere bekende functies van Eric Quéméneur
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Comité de l’énergie Atomique | Corporate Officer/Principal | 01-09-2010 | 01-09-2014 |
Opleiding van Eric Quéméneur
| Université Claude Bernard Lyon 1 | Doctorate Degree |
| Institut National des Sciences Appliquées de Lyon | Undergraduate Degree |
Statistieken
Internationaal
| Frankrijk | 6 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Government | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TRANSGENE | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Comité de l’énergie Atomique | Government |
ElsaLys Biotech SAS
 ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology ElsaLys Biotech SAS provides therapeutic monoclonal antibody player services. It involves in cellular events at the core of the pathological process: immune response, angiogenesis, survival, proliferation, adhesion and migration. The company also designs and develops a new generation of antibodies that target tumors and their immune microenvironment. ElsaLys Biotech was founded by Christine Guillen, Thierry Menguy, Vanessa Duong, and Martine Brandt in 2013 and is headquartered in Lyon, France. | Health Technology |
- Beurs
- Insiders
- Eric Quéméneur
- Ervaring
